TW200636076A - Method for measuring resistance or sensitivity to docetaxel - Google Patents

Method for measuring resistance or sensitivity to docetaxel

Info

Publication number: TW200636076A
Authority: TW; Taiwan
Prior art keywords: docetaxel; sensitivity; measuring resistance; predict; molecule
Prior art date: 2004-12-08

Application number

TW094143285A

Other languages

English (en)

Inventor

Dorre Grueneberg

Xi Huang

Sridaran Natesan

Paul August

Original Assignee

Aventis Pharma Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-12-08

Filing date

2005-12-08

Publication date

2006-10-16

2005-12-08 Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc

2006-10-16 Publication of TW200636076A publication Critical patent/TW200636076A/zh

Links

ZDZOTLJHXYCWBA-VCVYQWHSSA-N N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol Chemical compound O([C@H]1[C@H]2[C@@](C([C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C=4C=CC=CC=4)C[C@]1(O)C3(C)C)=O)(C)[C@@H](O)C[C@H]1OC[C@]12OC(=O)C)C(=O)C1=CC=CC=C1 ZDZOTLJHXYCWBA-VCVYQWHSSA-N 0.000 title 1
229960003668 docetaxel Drugs 0.000 title 1
230000035945 sensitivity Effects 0.000 title 1
230000002068 genetic effect Effects 0.000 abstract 2
108091005461 Nucleic proteins Proteins 0.000 abstract 1
102000039446 nucleic acids Human genes 0.000 abstract 1
108020004707 nucleic acids Proteins 0.000 abstract 1
150000007523 nucleic acids Chemical class 0.000 abstract 1
102000004169 proteins and genes Human genes 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Molecular Biology (AREA)
Analytical Chemistry (AREA)
Pathology (AREA)
Biomedical Technology (AREA)
Hematology (AREA)
Urology & Nephrology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Organic Chemistry (AREA)
Microbiology (AREA)
Biotechnology (AREA)
Physics & Mathematics (AREA)
Biochemistry (AREA)
General Health & Medical Sciences (AREA)
Wood Science & Technology (AREA)
Zoology (AREA)
Genetics & Genomics (AREA)
Cell Biology (AREA)
General Physics & Mathematics (AREA)
Medicinal Chemistry (AREA)
Food Science & Technology (AREA)
Oncology (AREA)
Hospice & Palliative Care (AREA)
Biophysics (AREA)
Bioinformatics & Cheminformatics (AREA)
General Engineering & Computer Science (AREA)
Tropical Medicine & Parasitology (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

TW094143285A 2004-12-08 2005-12-08 Method for measuring resistance or sensitivity to docetaxel TW200636076A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US63429804P	2004-12-08	2004-12-08

Publications (1)

Publication Number	Publication Date
TW200636076A true TW200636076A (en)	2006-10-16

Family

ID=36512512

Family Applications (10)

Application Number	Title	Priority Date	Filing Date
TW101120202A TW201237174A (en)	2004-12-08	2005-12-08	Method for measuring resistance or sensitivity to Docetaxel
TW101120209A TW201237178A (en)	2004-12-08	2005-12-08	Method for measuring resistance or sensitivity to Docetaxel
TW101120204A TW201241177A (en)	2004-12-08	2005-12-08	Method for measuring resistance or sensitivity to Docetaxel
TW101120203A TW201241176A (en)	2004-12-08	2005-12-08	Method for measuring resistance or sensitivity to Docetaxel
TW101120210A TW201237179A (en)	2004-12-08	2005-12-08	Method for measuring resistance or sensitivity to Docetaxel
TW101120208A TW201237177A (en)	2004-12-08	2005-12-08	Method for measuring resistance or sensitivity to Docetaxel
TW101120207A TW201241178A (en)	2004-12-08	2005-12-08	Method for measuring resistance or sensitivity to Docetaxel
TW101120205A TW201237175A (en)	2004-12-08	2005-12-08	Method for measuring resistance or sensitivity to Docetaxel
TW101120206A TW201237176A (en)	2004-12-08	2005-12-08	Method for measuring resistance or sensitivity to Docetaxel
TW094143285A TW200636076A (en)	2004-12-08	2005-12-08	Method for measuring resistance or sensitivity to docetaxel

Family Applications Before (9)

Application Number	Title	Priority Date	Filing Date
TW101120202A TW201237174A (en)	2004-12-08	2005-12-08	Method for measuring resistance or sensitivity to Docetaxel
TW101120209A TW201237178A (en)	2004-12-08	2005-12-08	Method for measuring resistance or sensitivity to Docetaxel
TW101120204A TW201241177A (en)	2004-12-08	2005-12-08	Method for measuring resistance or sensitivity to Docetaxel
TW101120203A TW201241176A (en)	2004-12-08	2005-12-08	Method for measuring resistance or sensitivity to Docetaxel
TW101120210A TW201237179A (en)	2004-12-08	2005-12-08	Method for measuring resistance or sensitivity to Docetaxel
TW101120208A TW201237177A (en)	2004-12-08	2005-12-08	Method for measuring resistance or sensitivity to Docetaxel
TW101120207A TW201241178A (en)	2004-12-08	2005-12-08	Method for measuring resistance or sensitivity to Docetaxel
TW101120205A TW201237175A (en)	2004-12-08	2005-12-08	Method for measuring resistance or sensitivity to Docetaxel
TW101120206A TW201237176A (en)	2004-12-08	2005-12-08	Method for measuring resistance or sensitivity to Docetaxel

Country Status (15)

Country	Link
US (2)	US20090226894A1 (zh)
EP (10)	EP2395104A1 (zh)
JP (5)	JP5139811B2 (zh)
KR (10)	KR101357040B1 (zh)
CN (10)	CN102605066A (zh)
AR (1)	AR051523A1 (zh)
AU (1)	AU2005314335C1 (zh)
BR (1)	BRPI0518884A2 (zh)
CA (1)	CA2589918A1 (zh)
IL (9)	IL183718A (zh)
MX (1)	MX2007006867A (zh)
RU (2)	RU2403574C2 (zh)
SG (2)	SG156625A1 (zh)
TW (10)	TW201237174A (zh)
WO (1)	WO2006062811A2 (zh)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0606096D0 (en)	2006-03-27	2006-05-03	Cbmm Sa	Screening method
EP2468887A1 (en) *	2006-12-13	2012-06-27	Oncotherapy Science, Inc.	TTK as tumor marker and therapeutic target for lung cancer
DK2134374T3 (en) *	2007-03-14	2014-02-24	Bionsil S R L In Liquidazione	BTK-INHIBITORS FOR USE IN PROCESSING chemotherapeutic agent RESISTANT TUMORS Epithelial
EP2227693B1 (en) *	2007-11-30	2015-08-19	Clarient Diagnostic Services, Inc.	Tle3 as a marker for chemotherapy
EP2177630A1 (en)	2008-10-02	2010-04-21	Institut Gustave Roussy	Methods for predicting or monitoring whether a patient affected by a cancer is responsive to a treatment with a molecule of the taxoid family
TW201102081A (en)	2009-05-11	2011-01-16	Oncotherapy Science Inc	TTK peptides and vaccines including the same
PL2493466T3 (pl)	2009-10-29	2021-11-15	Sanofi Mature Ip	Nowe przeciwguzowe zastosowanie kabazytakselu
US20130130928A1 (en)	2010-04-08	2013-05-23	Institut Gustave Roussy	Methods for predicting or monitoring whether a patient affected by a cancer is responsive to a treatment with a molecule of the taxoid family
JP2012005479A (ja) *	2010-05-26	2012-01-12	Japanese Foundation For Cancer Research	抗癌剤のスクリーニング方法
JP6302673B2 (ja) *	2011-01-21	2018-03-28	バジリアファルマスーチカアーゲーＢａｓｉｌｅａＰｈａｒｍａｃｅｕｔｉｃａＡＧ	フラザノベンゾイミダゾールに対する薬物応答のバイオマーカーとしてのｂｕｂｒ１の使用
US9976183B2 (en) *	2011-11-21	2018-05-22	Taivex Therapeutics Corporation	Biomarkers for cancers responsive to modulators of HEC1 activity
CA2857191A1 (en) *	2011-11-28	2013-06-06	National Research Council Of Canada	Paclitaxel response markers for cancer
CN102621325B (zh) *	2012-04-06	2014-11-12	上海蓝怡科技有限公司	用于检测血液中多西他赛浓度的试剂盒
CN105803053B (zh) *	2014-12-31	2021-03-16	上海吉凯基因科技有限公司	人rbm17基因的用途及其相关药物
CN105925611A (zh) *	2016-04-23	2016-09-07	同济大学苏州研究院	靶向hsp70基因rna干扰重组慢病毒载体及其构建方法
CN107447028A (zh) *	2017-09-13	2017-12-08	赵小刚	检测rb1基因i680t位点突变的试剂盒
CN108931633B (zh) *	2018-05-22	2021-08-27	郑州大学第一附属医院	胆囊癌诊断和预后判断标志物pim1
CN111944905B (zh) *	2020-08-20	2023-06-02	武汉凯德维斯医学检验实验室有限公司	人类基因组合及其在制备评估宫颈癌新辅助化疗药物敏感性试剂盒中的应用
KR102605155B1 (ko)	2022-03-04	2023-11-23	우순	다기능 표적 이송장치
KR102596893B1 (ko)	2022-03-04	2023-11-01	우순	표적지 이송장치
CN115078034B (zh) *	2022-06-30	2025-06-24	江南大学	一种适用于有机质谱的单细胞周期标记方法及其在单细胞周期鉴定中的应用

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NL7807532A (nl)	1978-07-13	1980-01-15	Akzo Nv	Metaal-immunotest.
NL8000173A (nl)	1980-01-11	1981-08-03	Akzo Nv	Toepassing van in water dispergeerbare, hydrofobe kleurstoffen als label in immunochemische testen.
US4816567A (en)	1983-04-08	1989-03-28	Genentech, Inc.	Recombinant immunoglobin preparations
US4703017C1 (en)	1984-02-14	2001-12-04	Becton Dickinson Co	Solid phase assay with visual readout
JPS61231031A (ja) *	1985-04-08	1986-10-15	Agency Of Ind Science & Technol	二硫化炭素重合体の製造方法
US5225539A (en)	1986-03-27	1993-07-06	Medical Research Council	Recombinant altered antibodies and methods of making altered antibodies
EP0280559B1 (en)	1987-02-27	1993-10-20	EASTMAN KODAK COMPANY (a New Jersey corporation)	Agglutination immunoassay and kit for determination of a multivalent immune species using a buffered salt wash solution
EP0281327B1 (en)	1987-02-27	1993-06-30	EASTMAN KODAK COMPANY (a New Jersey corporation)	Immunoreactive reagent, method of preparation and its use to determine an immunoreactive species
US4857453A (en) *	1987-04-07	1989-08-15	Syntex (U.S.A.) Inc.	Immunoassay device
ATE195022T1 (de)	1987-04-27	2000-08-15	Unilever Nv	Spezifische bindungstestverfahren
US5530101A (en)	1988-12-28	1996-06-25	Protein Design Labs, Inc.	Humanized immunoglobulins
US5859205A (en)	1989-12-21	1999-01-12	Celltech Limited	Humanised antibodies
US5834298A (en) *	1995-08-01	1998-11-10	Sloan-Kettering Institute For Cancer Research	Gene encoding the human homolog of MAD2
JP2002508658A (ja) *	1997-06-11	2002-03-19	カイロンコーポレイション	野生型ｈｕＢＵＢ１遺伝子の減少の検出
US6410312B1 (en) *	1997-12-19	2002-06-25	Chiron Corporation	huBUB3 gene involved in human cancers
AU750564B2 (en) *	1997-11-27	2002-07-25	Chugai Seiyaku Kabushiki Kaisha	Examination method, examination reagent and remedy for diseases caused by variation in LKB1 gene
EP1057029B1 (en) *	1998-02-18	2003-04-23	Theryte Limited	Treating cancer
AU6162999A (en) *	1998-09-24	2000-04-10	Promega Corporation	Apoptosis marker antibodies and methods of use
AU2055300A (en) *	1998-12-18	2000-07-03	Scios Inc.	Methods for detection and use of differentially expressed genes in disease states
US20020120004A1 (en) *	2000-02-17	2002-08-29	Roth Frederick P.	Methods and compositions for the identification, assessment, prevention and therapy of human cancers
AU2001238493A1 (en) *	2000-02-17	2001-08-27	Millennium Pharmaceuticals, Inc	Methods and compositions for the identification, assessment, prevention and therapy of human cancers
CN101732717A (zh) *	2001-02-21	2010-06-16	诺华疫苗和诊断公司	用于诊断和作为癌症治疗靶标的ttk
US6783597B2 (en) *	2001-03-13	2004-08-31	3M Innovative Properties Company	Filament recoating apparatus and method
US7229774B2 (en) *	2001-08-02	2007-06-12	Regents Of The University Of Michigan	Expression profile of prostate cancer
DE10139283A1 (de) *	2001-08-09	2003-03-13	Epigenomics Ag	Verfahren und Nukleinsäuren zur Analyse von Colon-Krebs
US20030235581A1 (en) *	2002-06-20	2003-12-25	George Pieczenik	Ligands for Reproductive Science
ES2359055T3 (es) *	2002-09-11	2011-05-18	Genentech, Inc.	Composiciones y métodos para el diagnóstico y el tratamiento de tumores.
AU2003300899A1 (en) *	2002-12-12	2004-06-30	Oncotech, Inc.	Genes related to sensitivity and resistance to chemotherapeutic drug treatment
DE10260264A1 (de) *	2002-12-20	2004-07-01	GSF-Forschungszentrum für Umwelt und Gesundheit GmbH	Verfahren und Zelllinie zur Identifizierung proliferationshemmender, anti-inflammatorischer oder proliferationsfördender Wirkstoffe
EP1661991A4 (en) *	2003-08-24	2007-10-10	Univ Nihon	WITH HEPATOCELLULAR CARCINOMA ASSOCIATED GEN
US20050136177A1 (en) *	2003-08-25	2005-06-23	Anthony Hesse	Method for coloring landscaping materials using foamable dry colorant
ES2636470T3 (es) *	2004-04-09	2017-10-05	Genomic Health, Inc.	Marcadores de expresión génica para predecir la respuesta a la quimioterapia
JP2006014722A (ja) *	2004-06-02	2006-01-19	Keio Gijuku	遺伝子マーカー及びその利用
GB0426393D0 (en) *	2004-12-01	2005-01-05	Cancer Rec Tech Ltd	Materials and methods relating to modulators of spindle checkpoint kinases
US7957910B2 (en) *	2005-01-31	2011-06-07	Sysmex Corporation	Method for predicting effectiveness of chemotherapy
EP2177630A1 (en) *	2008-10-02	2010-04-21	Institut Gustave Roussy	Methods for predicting or monitoring whether a patient affected by a cancer is responsive to a treatment with a molecule of the taxoid family

2005
- 2005-12-01 AU AU2005314335A patent/AU2005314335C1/en not_active Ceased
- 2005-12-01 KR KR1020137023647A patent/KR101357040B1/ko not_active Expired - Fee Related
- 2005-12-01 EP EP11003913A patent/EP2395104A1/en not_active Withdrawn
- 2005-12-01 CN CN2012100674486A patent/CN102605066A/zh active Pending
- 2005-12-01 EP EP11003912A patent/EP2395103A1/en not_active Withdrawn
- 2005-12-01 JP JP2007545523A patent/JP5139811B2/ja not_active Expired - Fee Related
- 2005-12-01 EP EP05852717.7A patent/EP1831398B1/en not_active Expired - Lifetime
- 2005-12-01 CN CN201210071753.2A patent/CN102618641B/zh not_active Expired - Fee Related
- 2005-12-01 CA CA002589918A patent/CA2589918A1/en not_active Withdrawn
- 2005-12-01 CN CN2005800418473A patent/CN101072883B/zh not_active Expired - Fee Related
- 2005-12-01 EP EP11003919A patent/EP2395110A1/en not_active Withdrawn
- 2005-12-01 KR KR1020137023625A patent/KR101357033B1/ko not_active Expired - Fee Related
- 2005-12-01 SG SG200906735-6A patent/SG156625A1/en unknown
- 2005-12-01 US US11/721,103 patent/US20090226894A1/en not_active Abandoned
- 2005-12-01 EP EP11003916A patent/EP2395107A1/en not_active Withdrawn
- 2005-12-01 RU RU2007125722/15A patent/RU2403574C2/ru not_active IP Right Cessation
- 2005-12-01 KR KR1020137023637A patent/KR101357038B1/ko not_active Expired - Fee Related
- 2005-12-01 EP EP11003911A patent/EP2395102A1/en not_active Withdrawn
- 2005-12-01 EP EP11003914A patent/EP2395105A1/en not_active Withdrawn
- 2005-12-01 KR KR1020137020949A patent/KR101347107B1/ko not_active Expired - Fee Related
- 2005-12-01 MX MX2007006867A patent/MX2007006867A/es active IP Right Grant
- 2005-12-01 KR KR1020077013060A patent/KR101323574B1/ko not_active Expired - Fee Related
- 2005-12-01 KR KR1020127030823A patent/KR101347106B1/ko not_active Expired - Fee Related
- 2005-12-01 CN CN2012100719082A patent/CN102747142A/zh active Pending
- 2005-12-01 EP EP11003918A patent/EP2395109A1/en not_active Withdrawn
- 2005-12-01 KR KR1020137023633A patent/KR101357037B1/ko not_active Expired - Fee Related
- 2005-12-01 EP EP11003915A patent/EP2395106A1/en not_active Withdrawn
- 2005-12-01 CN CN2010102549551A patent/CN101974619B/zh not_active Expired - Fee Related
- 2005-12-01 BR BRPI0518884-9A patent/BRPI0518884A2/pt not_active IP Right Cessation
- 2005-12-01 CN CN201210067055.5A patent/CN102634574B/zh not_active Expired - Fee Related
- 2005-12-01 CN CN2012100717833A patent/CN102747140A/zh active Pending
- 2005-12-01 KR KR1020137023626A patent/KR101357035B1/ko not_active Expired - Fee Related
- 2005-12-01 WO PCT/US2005/043578 patent/WO2006062811A2/en not_active Ceased
- 2005-12-01 CN CN2012100718501A patent/CN102747141A/zh active Pending
- 2005-12-01 KR KR1020137023642A patent/KR101357039B1/ko not_active Expired - Fee Related
- 2005-12-01 CN CN2012100674611A patent/CN102605067A/zh active Pending
- 2005-12-01 EP EP11003917A patent/EP2395108A1/en not_active Withdrawn
- 2005-12-01 CN CN201210071822.XA patent/CN102618642B/zh not_active Expired - Fee Related
- 2005-12-01 SG SG2013065594A patent/SG194337A1/en unknown
- 2005-12-01 KR KR1020137023621A patent/KR101357032B1/ko not_active Expired - Fee Related
- 2005-12-06 AR ARP050105086A patent/AR051523A1/es unknown
- 2005-12-08 TW TW101120202A patent/TW201237174A/zh unknown
- 2005-12-08 TW TW101120209A patent/TW201237178A/zh unknown
- 2005-12-08 TW TW101120204A patent/TW201241177A/zh unknown
- 2005-12-08 TW TW101120203A patent/TW201241176A/zh unknown
- 2005-12-08 TW TW101120210A patent/TW201237179A/zh unknown
- 2005-12-08 TW TW101120208A patent/TW201237177A/zh unknown
- 2005-12-08 TW TW101120207A patent/TW201241178A/zh unknown
- 2005-12-08 TW TW101120205A patent/TW201237175A/zh unknown
- 2005-12-08 TW TW101120206A patent/TW201237176A/zh unknown
- 2005-12-08 TW TW094143285A patent/TW200636076A/zh unknown
2007
- 2007-06-06 IL IL183718A patent/IL183718A/en not_active IP Right Cessation
2010
- 2010-05-09 IL IL205636A patent/IL205636A/en not_active IP Right Cessation
- 2010-05-09 IL IL205635A patent/IL205635A/en not_active IP Right Cessation
- 2010-05-11 IL IL205702A patent/IL205702A0/en not_active IP Right Cessation
- 2010-06-03 RU RU2010122759/15A patent/RU2010122759A/ru not_active Application Discontinuation
- 2010-12-27 IL IL210299A patent/IL210299A/en not_active IP Right Cessation
- 2010-12-27 IL IL210298A patent/IL210298A/en not_active IP Right Cessation
2011
- 2011-12-14 JP JP2011273355A patent/JP5531001B2/ja not_active Expired - Fee Related
- 2011-12-14 JP JP2011273353A patent/JP5530999B2/ja not_active Expired - Fee Related
- 2011-12-14 JP JP2011273356A patent/JP5531002B2/ja not_active Expired - Fee Related
- 2011-12-14 JP JP2011273354A patent/JP5531000B2/ja not_active Expired - Fee Related
2012
- 2012-09-04 IL IL221772A patent/IL221772A/en not_active IP Right Cessation
2013
- 2013-03-15 US US13/833,367 patent/US20130252837A1/en not_active Abandoned
- 2013-03-24 IL IL225469A patent/IL225469A0/en unknown
- 2013-03-24 IL IL225468A patent/IL225468A0/en unknown

Also Published As

Publication number	Publication date
AU2005314335B2 (en)	2012-02-02
SG156625A1 (en)	2009-11-26
TW201237176A (en)	2012-09-16
TW201241178A (en)	2012-10-16
KR20130105759A (ko)	2013-09-25
IL221772A (en)	2014-06-30
TW201237177A (en)	2012-09-16
KR101357033B1 (ko)	2014-02-03
WO2006062811A3 (en)	2006-09-14
CN102634574A (zh)	2012-08-15
CN102605067A (zh)	2012-07-25
TW201237174A (en)	2012-09-16
IL210298A (en)	2012-12-31
JP2012100665A (ja)	2012-05-31
IL205702A0 (en)	2011-07-31
TW201241177A (en)	2012-10-16
BRPI0518884A2 (pt)	2008-12-30
TW201237175A (en)	2012-09-16
IL221772A0 (en)	2012-10-31
KR20130105760A (ko)	2013-09-25
SG194337A1 (en)	2013-11-29
TW201241176A (en)	2012-10-16
AR051523A1 (es)	2007-01-17
IL205636A (en)	2012-08-30
IL210299A0 (en)	2011-03-31
EP2395106A1 (en)	2011-12-14
EP2395102A1 (en)	2011-12-14
CN102605066A (zh)	2012-07-25
JP5530999B2 (ja)	2014-06-25
AU2005314335C1 (en)	2012-08-16
JP2012115267A (ja)	2012-06-21
KR20130099246A (ko)	2013-09-05
EP1831398B1 (en)	2014-10-29
EP2395103A1 (en)	2011-12-14
EP2395110A1 (en)	2011-12-14
CN101072883A (zh)	2007-11-14
EP1831398A2 (en)	2007-09-12
KR101323574B1 (ko)	2013-10-30
IL225468A0 (en)	2013-06-27
MX2007006867A (es)	2007-08-06
JP5531000B2 (ja)	2014-06-25
KR20130105762A (ko)	2013-09-25
CN102618642B (zh)	2014-12-31
KR20070085986A (ko)	2007-08-27
KR101357037B1 (ko)	2014-02-03
KR101357035B1 (ko)	2014-02-03
WO2006062811A2 (en)	2006-06-15
EP2395105A1 (en)	2011-12-14
EP2395108A1 (en)	2011-12-14
US20130252837A1 (en)	2013-09-26
CN102747141A (zh)	2012-10-24
KR101347106B1 (ko)	2014-01-02
KR101357040B1 (ko)	2014-02-03
KR20130105758A (ko)	2013-09-25
CN102618642A (zh)	2012-08-01
CN102747140A (zh)	2012-10-24
TW201237179A (en)	2012-09-16
IL210299A (en)	2012-12-31
IL183718A (en)	2013-04-30
JP5139811B2 (ja)	2013-02-06
JP2008522615A (ja)	2008-07-03
EP2395109A1 (en)	2011-12-14
IL225469A0 (en)	2013-06-27
CN102618641B (zh)	2014-08-13
KR101347107B1 (ko)	2014-01-02
AU2005314335A1 (en)	2006-06-15
KR101357032B1 (ko)	2014-02-03
EP2395104A1 (en)	2011-12-14
IL210298A0 (en)	2011-03-31
CN101974619A (zh)	2011-02-16
KR20130113526A (ko)	2013-10-15
RU2007125722A (ru)	2009-01-20
CN101974619B (zh)	2012-11-21
TW201237178A (en)	2012-09-16
JP2012100666A (ja)	2012-05-31
EP2395107A1 (en)	2011-12-14
KR101357039B1 (ko)	2014-02-03
HK1153786A1 (zh)	2012-04-05
JP5531002B2 (ja)	2014-06-25
KR101357038B1 (ko)	2014-02-03
IL205635A (en)	2013-02-28
IL183718A0 (en)	2007-09-20
CN102634574B (zh)	2014-11-12
CN102618641A (zh)	2012-08-01
KR20130113527A (ko)	2013-10-15
KR20130004381A (ko)	2013-01-09
CN101072883B (zh)	2012-05-23
KR20130105761A (ko)	2013-09-25
CA2589918A1 (en)	2006-06-15
RU2403574C2 (ru)	2010-11-10
CN102747142A (zh)	2012-10-24
JP5531001B2 (ja)	2014-06-25
HK1111441A1 (zh)	2008-08-08
JP2012120532A (ja)	2012-06-28
RU2010122759A (ru)	2011-12-10
US20090226894A1 (en)	2009-09-10

Publication	Publication Date	Title
TW200636076A (en)	2006-10-16	Method for measuring resistance or sensitivity to docetaxel
Zebrick et al.	2014	ACTN3 R577X genotypes associate with Class II and deepbite malocclusions
Chong et al.	2013	Fibroblast growth factor 2 drives changes in gene expression following injury to murine cartilage in vitro and in vivo
EP2185931A4 (en)	2011-01-19	USE OF SECRETOR, LEWIS AND SIALYL-ANTIGEN CONCENTRATIONS AS DISEASE PROSPECTS INDICATORS
TW200745556A (en)	2007-12-16	Biomarkers for liver fibrotic injury
UA93989C2 (ru)	2011-03-25	Способ прогнозирования otbeta ha лечение
WO2008069975A3 (en)	2008-12-11	Methods of using f-spondin as a biomarker for cartilage degenerative conditions
NZ581742A (en)	2012-09-28	Biomarkers for predicting anti-tnf responsiveness or non-responsiveness
HU0400904D0 (en)	2004-07-28	Use of genes as molecular markers in diagnosis of schizophrenia and diagnostic kit for the same
WO2004046729A3 (en)	2004-07-22	Bodily fluid markers of tissue hypoxia
ATE478062T1 (de)	2010-09-15	Zusammensetzungen und verfahren zur in vivo abbildung von loeslichen beta-amyloid
EP2021794B8 (en)	2010-08-18	Use of protein s100a 12 as a marker for colorectal cancer
DE602004016499D1 (de)	2008-10-23	Zusammensetzungen und verfahren zur behandlung von entzündlicher darmerkrankung
WO2005059108A3 (en)	2006-04-20	Gene expression profiles and methods of use
WO2008073177A3 (en)	2008-11-06	Expression profiles associated with irinotecan treatment
WO2006055524A3 (en)	2008-12-24	Biomarkers for diagnosing schizophrenia and bipolar disorder
WO2005032495A3 (en)	2006-06-01	Gene expression profiles and methods of use
MXPA02008239A (es)	2004-08-12	Gen humano de la esquizofrenia.
WO2005098433A3 (en)	2006-12-28	Diagnostic assays for alzheimer’s disease
ATE432997T1 (de)	2009-06-15	Therapieüberwachung für tumoren unter benutzung acc133 mrna
WO2007121319A3 (en)	2008-12-04	Compostions and methods for determining and predicting treatment responses for depression and anxiety
WO2005085473A3 (en)	2006-03-02	Polymorphisms in the epidermal growth factor receptor gene promoter
DE602008004556D1 (de)	2011-02-24	Zusammensetzungen und verfahren zum nachweis von störungen in verbindung mit histamin
DE602007004570D1 (de)	2010-03-18	Verwendung von Nogo-C bei der Beurteilung von Herzversagen
TW200734638A (en)	2007-09-16	Method for the diagnosis of thromboembolic and coronary heart diseases